View of Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial

Return to Article Details Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial Download Download PDF